The leader in fluorescence visualization. The VELscope system is the first oral cancer screening device to incorporate fluorescence visualization technology to help detect abnormal tissue , including cancer and precancer. The science behind tissue this technology has been supported by over $50 million in research funded by the National Institutes of Health and other prestigious organizations.
A way to see what might otherwise be missed. The VELscope system is the first adjunctive device cleared by the FDA and Health Canada to help clinicians see cancerous and precancerous lesions that might not be visible to the naked eye. The VELscope is also the first device cleared to help surgeons determine the appropriate surgical margins if surgery is indicated. This is extremely important, as oral surgery often fails to remove 100% of the targeted tissue.
Easy for clinicians - and for patients. VELscope exams may be given as part of a normal hygiene exam. The exam is easy for dentists and hygienists to administer, taking only 2-to-3 minutes. It is completely free of pain or discomfort for the patients, and it involves no distasteful rinses or messy dyes like some other systems.